Hemophilia And Rare Diseases Drive European Mid-Pharmas Sobi And Recordati
Executive Summary
Sweden’s Swedish Orphan Biovitrum and Italy’s Recordati are looking towards hemophilia and rare diseases to keep up the growth of their businesses, and Q3 results have highlighted the Swedish company in particular as a potential takeover target.